Recent progress in the treatment of childhood acute leukaemia
Willoughby, M.L.
Nouvelle Revue Francaise d'Hematologie 12(3): 365-371
1972
ISSN/ISBN: 0029-4810 PMID: 4266207 Document Number: 56149
Document emailed within 1 workday
Related Documents
Hann, I.; Vora, A.; Richards, S.; Hill, F.; Gibson, B.; Lilleyman, J.; Kinsey, S.; Mitchell, C.; Eden, O.B. 2000: Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia Leukemia 14(3): 356-363Liesner, R.; Goldstone, A.H. 1997: Treatment of childhood and adult acute lymphoblastic leukaemia Journal of Internal Medicine. Suppl 740: 29-36
Kudva, G.C.; Chandy, M.; Raghupathy, P.; Dennison, D.; Srivastava, A.; Bhushan, V.; Singh, R. 1994: Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen Indian Journal of Cancer 31(2): 78-85
Bowman, W.P. 1981: Childhood acute lymphocytic leukemia: progress and problems in treatment Canadian Medical Association Journal 124(2): 129-142
Stopera, S.A.; Ray, M. 1989: Expression and distribution of aphidicolin-induced fragile sites in chronic myeloid leukaemia, acute lymphocytic leukaemia and acute myeloid leukaemia Cytobios 60(241): 103-109
Greaves, M.F. 1991: Models of childhood acute lymphoblastic leukaemia Leukemia 5(9): 819-820
Batinić, D.; Boranić, M.; Tiefenbach, A.; Rajić, L.; Femenić-Kes, R.; Konja, J. 1988: Subsets of childhood acute lymphoblastic leukaemia in Croatia Biomedicine and PharmacoTherapy 42(2): 133-134
Sinniah, D.; Looi, L.M.; Ortega, J.A.; Siegel, S.E.; Landing, B. 1982: Cerebellar coning and uncal herniation in childhood acute leukaemia Lancet 2(8300): 702-704
Ekem, I. 2000: Childhood acute lymphoblastic leukaemia (ALL) in Ghanaians and Germans--a comparative study West African Journal of Medicine 19(1): 50-54
Yeoh, A.E.; Quah, T.C.; Jeyaseelan, K.; Lee, B.W.; Poh, K.S.; Sun, L. 1997: An evaluation of minimal residual disease in childhood acute lymphoblastic leukaemia Annals of the Academy of Medicine Singapore 26(3): 365-371
Kis, M. 2005: Time series models on analysing mortality rates and acute childhood lymphoid leukaemia Studies in Health Technology and Informatics 116: 15-20
Pieters, R.; Huismans, D.R.; Loonen, A.H.; Hählen, K.; van der Does-van den Berg, A.; van Wering, E.R.; Veerman, A.J. 1991: Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia Lancet 338(8764): 399-403
Schroeder, H.; Pinkerton, C.R.; Powles, R.L.; Meller, S.T.; Tait, D.; Milan, S.; Mcelwain, T.J. 1991: High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse Bone Marrow Transplantation 7(1): 11-15
Chessells, J.M.; Bailey, C.C.; Richards, S. 1992: MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia Leukemia 6 Suppl. 2: 157-161
Wöhrer, S.; Rabitsch, W.; Shehata, M.; Kondo, R.; Esterbauer, H.; Streubel, B.; Sillaber, C.; Raderer, M.; Jaeger, U.; Zielinski, C.; Valent, P. 2007: Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone Anticancer Research 27(6b): 3837-3841
Löwenberg, B. 1997: Treatment of acute myelogenous leukaemia Journal of Internal Medicine. Supplement 740: 17-22
Labar, B.; Nemet, D.; Minigo, H.; Bogdanić, V.; Jaksić, B.; Malesević, M.; Mrsić, M. 1989: Aclarubicin in the treatment of de-novo acute myelocytic leukaemia Bone Marrow Transplantation 4(Suppl): 45-46
Amiel, J.L. 1977: Simple propositions in the treatment of acute lymphoblastic leukaemia La Nouvelle Presse Medicale 6(29): 2595-2597
Melo, J.V.; Goldman, J.M. 1992: Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia Leukemia 6(8): 786-790
Jones, L. 1996: Progress in treating leukaemia Practitioner 240(1559): 80-86